Epigenetic Modifiers in Cancer Metastasis

被引:2
|
作者
Hu, Die [1 ,2 ,3 ]
Zhao, Tianci [4 ,5 ]
Xu, Chenxing [3 ]
Pan, Xinyi [3 ]
Zhou, Zhengyu [1 ,2 ,6 ]
Wang, Shengjie [1 ,2 ,3 ,6 ]
机构
[1] Nanjing Med Univ, Kangda Coll, Key Lab Mol Genet, Suzhou 215123, Peoples R China
[2] Soochow Univ, Suzhou Med Coll, Key Lab Mol Genet, Suzhou 215123, Peoples R China
[3] Nanjing Med Univ, Kangda Coll, Dept Basic Med, Lianyungang 222000, Peoples R China
[4] China Med Univ, Minist Publ Hlth, Key Lab Cell Biol, Shenyang 110122, Peoples R China
[5] China Med Univ, Minist Educ, Key Lab Med Cell Biol, Shenyang 110122, Peoples R China
[6] Soochow Univ, Suzhou Med Coll, Lab Anim Ctr, Suzhou 215123, Jiangsu, Peoples R China
基金
中国国家自然科学基金;
关键词
epigenetics; DNA methylation; histone methylation; non-coding RNAs; metastasis; ENHANCER REPROGRAMMING PROMOTES; BREAST-CANCER; NONCODING RNA; LUNG METASTASIS; MESSENGER-RNA; LIVER-DISEASE; CELL; METHYLATION; GROWTH; CHROMATIN;
D O I
10.3390/biom14080916
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Metastasis is the primary cause of cancer-related death, with the dissemination and colonization of primary tumor cells at the metastatic site facilitated by various molecules and complex pathways. Understanding the biological mechanisms underlying the metastatic process is critical for the development of effective interventions. Several epigenetic modifications have been identified that play critical roles in regulating cancer metastasis. This review aims to provide a comprehensive summary of recent advances in understanding the role of epigenetic modifiers, including histone modifications, DNA methylation, non-coding RNAs, enhancer reprogramming, chromatin accessibility, and N6-methyladenosine, in metastasis-associated processes, such as epithelial-mesenchymal transition (EMT), cancer cell migration, and invasion. In particular, this review provides a detailed and in-depth description of the role of crosstalk between epigenetic regulators in tumor metastasis. Additionally, we explored the potential and limitations of epigenetics-related target molecules in the diagnosis, treatment, and prognosis of cancer metastasis.
引用
收藏
页数:23
相关论文
共 50 条
  • [21] Flavonoids and Other Polyphenols Act as Epigenetic Modifiers in Breast Cancer
    Selvakumar, Priyanga
    Badgeley, Aja
    Murphy, Paige
    Anwar, Hina
    Sharma, Urvashi
    Lawrence, Katharine
    Lakshmikuttyamma, Ashakumary
    NUTRIENTS, 2020, 12 (03)
  • [22] Alteration of Epigenetic Modifiers in Pancreatic Cancer and Its Clinical Implication
    Hung, Yu-Hsuan
    Hsu, Ming-Chuan
    Chen, Li-Tzong
    Hung, Wen-Chun
    Pan, Mei-Ren
    JOURNAL OF CLINICAL MEDICINE, 2019, 8 (06)
  • [23] Epigenetic modifications of metastasis suppressor genes in colon cancer metastasis
    Li, Qian
    Chen, Hong
    EPIGENETICS, 2011, 6 (07) : 849 - 852
  • [24] The progression of cancer and metastasis formation: An epigenetic hypothesis
    Alelu-Paz, R.
    JOURNAL OF MEDICAL HYPOTHESES AND IDEAS, 2015, 9 (01): : 20 - 23
  • [25] An epigenetic signature of advanced colorectal cancer metastasis
    Rodger, Euan J.
    Gimenez, Gregory
    Ajithkumar, Priyadarshana
    Stockwell, Peter A.
    Almomani, Suzan
    Bowden, Sarah A.
    Leichter, Anna L.
    Ahn, Antonio
    Pattison, Sharon
    McCall, John L.
    Schmeier, Sebastian
    Frizelle, Frank A.
    Eccles, Michael R.
    Purcell, Rachel V.
    Chatterjee, Aniruddha
    ISCIENCE, 2023, 26 (06)
  • [26] The role of epigenetic modifications in Colorectal Cancer Metastasis
    Su, Riya
    Wu, Xinlin
    Tao, Liang
    Wang, Changshan
    CLINICAL & EXPERIMENTAL METASTASIS, 2022, 39 (04) : 521 - 539
  • [27] Epigenetic Modifications in Prostate Cancer Metastasis and Microenvironment
    Zhang, Shouyi
    Shen, Tao
    Zeng, Yu
    CANCERS, 2023, 15 (08)
  • [28] The role of epigenetic modifications in Colorectal Cancer Metastasis
    Riya Su
    Xinlin Wu
    Liang Tao
    Changshan Wang
    Clinical & Experimental Metastasis, 2022, 39 : 521 - 539
  • [29] Immunological Effects of Epigenetic Modifiers
    Bezu, Lucillia
    Chuang, Alejandra Wu
    Liu, Peng
    Kroemer, Guido
    Kepp, Oliver
    CANCERS, 2019, 11 (12)
  • [30] Ketone bodies as epigenetic modifiers
    Ruan, Hai-Bin
    Crawford, Peter A.
    CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE, 2018, 21 (04): : 260 - 266